These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release. Karashima T; Cai RZ; Schally AV Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886 [TBL] [Abstract][Full Text] [Related]
3. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release. Meyers CA; Coy DH; Murphy WA; Redding TW; Arimura A; Schally AV Proc Natl Acad Sci U S A; 1980 Jan; 77(1):577-9. PubMed ID: 6987657 [TBL] [Abstract][Full Text] [Related]
4. Somatostatin-28 is longer acting and more selective than somatostatin-14 on pituitary and pancreatic hormone release. Tannenbaum GS; Ling N; Brazeau P Endocrinology; 1982 Jul; 111(1):101-7. PubMed ID: 6123428 [TBL] [Abstract][Full Text] [Related]
5. Somatostatin: analogs with selected biological activities. Brown M; Rivier J; Vale W Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045 [TBL] [Abstract][Full Text] [Related]
6. Position 4 substituted somatostatin analogs: increased binding to somatostatin receptors in pituitary and brain. Srikant CB; Coy DH; Patel YC Life Sci; 1983 Jul; 33(2):201-6. PubMed ID: 6135131 [TBL] [Abstract][Full Text] [Related]
7. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat. Brown M; Rivier J; Vale W Endocrinology; 1976 Feb; 98(2):336-43. PubMed ID: 813991 [TBL] [Abstract][Full Text] [Related]
8. Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells. Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Lamberts SW Endocrinology; 1994 Jan; 134(1):301-6. PubMed ID: 7903931 [TBL] [Abstract][Full Text] [Related]
9. The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. Adrian TE; Barnes AJ; Long RG; O'Shaughnessy DJ; Brown MR; Rivier J; Vale W; Blackburn AM; Bloom SR J Clin Endocrinol Metab; 1981 Oct; 53(4):675-81. PubMed ID: 6116721 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth hormone and glucagon release by Phe-4-somatostatin in patients with acromegaly. Charro AL; Cabranes JA; Lafuente A; Diaz-Salgado C; Cordero M; Almoguera I; Comaru-Schally AM; Meyers CA; Coy DH; Schally AV Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):432-44. PubMed ID: 6150529 [TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of sleep related growth hormone release by Phe-4-somatostatin. Cabranes JA; Vela A; Timoneda F; Meyers CA; Coy DH; Schally AV; Charro AL Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):421-31. PubMed ID: 6150528 [TBL] [Abstract][Full Text] [Related]
12. Delayed release formulation of the somatostatin analog RC-160 inhibits the growth hormone (GH) response to GH-releasing factor-(1-29)NH2 and decreases elevated prolactin levels in rats. Bokser L; Schally AV Endocrinology; 1988 Oct; 123(4):1735-9. PubMed ID: 2901338 [TBL] [Abstract][Full Text] [Related]
13. Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin. Afargan M; Janson ET; Gelerman G; Rosenfeld R; Ziv O; Karpov O; Wolf A; Bracha M; Shohat D; Liapakis G; Gilon C; Hoffman A; Stephensky D; Oberg K Endocrinology; 2001 Jan; 142(1):477-86. PubMed ID: 11145612 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat. Fries JL; Murphy WA; Sueiras-Diaz J; Coy DH Peptides; 1982; 3(5):811-4. PubMed ID: 6129618 [TBL] [Abstract][Full Text] [Related]
15. Highly active position eight analogues of somatostatin and separation of peptide diastereomers by partition chromatography. Meyers CA; Coy DH; Huang WY; Schally AV; Redding TW Biochemistry; 1978 Jun; 17(12):2326-31. PubMed ID: 678512 [TBL] [Abstract][Full Text] [Related]
17. [Action of [3,14-L-selenocysteine, 8-D-tryptophan]-somatostatin on insulin and glucagon secretion of the isolated perfused pancrease of the Wistar rat]. Bierwolf B; Hartrodt B; Neubert R; Jakubke HD; Blech W Biomed Biochim Acta; 1986; 45(5):611-8. PubMed ID: 2875714 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin. Murphy WA; Lance VA; Moreau S; Moreau JP; Coy DH Life Sci; 1987 Jun; 40(26):2515-22. PubMed ID: 2885701 [TBL] [Abstract][Full Text] [Related]
19. Development of specific and non-specific somatostatin analogs. Nakano T; Harano Y; Emura J; Kimura T; Sakakibara S; Shigeta Y Horm Metab Res; 1986 Feb; 18(2):98-102. PubMed ID: 2870971 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin. Cai RZ; Szoke B; Lu R; Fu D; Redding TW; Schally AV Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1896-900. PubMed ID: 2869490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]